Related Experiment Videos
Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans
Neena Jain1, Abraham Guerrero, Bettina C Fries
1All India Institute of Medical Sciences, New Delhi, India.
FEMS Yeast Research
|May 16, 2006
Summary
Cryptococcus neoformans phenotypic switching alters virulence and host response during chronic infections. This adaptability impacts disease outcomes and antifungal treatment effectiveness in patients.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Phenotypic switching is observed in Cryptococcus neoformans strains during chronic infections.
- This switching involves changes in the polysaccharide capsule and cell wall, affecting virulence and host immune responses.
Purpose of the Study:
- To investigate the biological relevance and implications of Cryptococcus neoformans phenotypic switching in vivo.
- To understand how phenotypic switching influences host-pathogen interactions and disease progression.
Main Methods:
- Analysis of differential gene expression associated with phenotypic switching.
- Evaluation of variant resistance to phagocytosis.
- Assessment of inflammatory responses elicited by switch variants in host models.
- Studies in murine infection models to demonstrate biological relevance.
Main Results:
- Phenotypic switching alters Cryptococcus neoformans virulence and immune evasion strategies.
- Switch variants elicit distinct inflammatory responses, influencing host immunity.
- The mucoid variant (RC-2 MC) increased intracranial pressure in a rat model, unlike the smooth variant (RC-2 SM).
- Antifungal interventions can select for more virulent switch variants during chronic murine infections.
Conclusions:
- Phenotypic switching is a critical factor in the pathogenesis of Cryptococcus neoformans infections.
- Understanding phenotypic switching is crucial for managing chronic cryptococcosis and developing effective antifungal strategies.
- The host immune response plays a role in selecting for specific switch variants during infection.